Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

2 treatments under study, led by Oncological Followup

Research Leaders

6 sponsors active, led by Cancer Research UK

Related Conditions

Often studied with 13 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

0.0%

0 terminated out of 2 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

50%

1 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

2Total
Phase 2 (1)
Phase 3 (1)

Trial Status

Recruiting1
Completed1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (2)

Showing 2 of 2 trials
NCT05500391Phase 2Recruiting

Assessment of Compliance With Monitoring Conducted by a Physician in Person or by a Nurse in Remote Monitoring

NCT01726374Phase 3CompletedPrimary

Trial of 1 Cycle of Adjuvant BEP Chemotherapy in High Risk, Stage 1 Non-seminomatous Germ Cell Testis Tumours

Showing all 2 trials

Research Network

Common Treatments

  • Oncological Followup1
  • Bep5001

Active Sponsors

  • Cancer Research UK1
  • Canceropôle Nord Ouest1
  • Centre Oscar Lambret1
  • University Hospital Birmingham NHS Foundation Trust1
  • Groupement Interrégional de Recherche Clinique et d'Innovation1

Top Investigators

Related Conditions

  • Aggressive Fibromatosis Of Abdominal Wall Disorder1
  • Adenocarcinoma Clear Cell1
  • Gastrointestinal Stromal Tumors1
  • Neuroendocrine Tumors1
  • Ovarian Germ Cell Tumor1

Activity Timeline